Oncternal Therapeutics Statistics

Total Valuation

BOM:534741 has a market cap or net worth of INR 211.83 million. The enterprise value is 232.86 million.

Market Cap	211.83M
Enterprise Value	232.86M

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

BOM:534741 has 423.66 million shares outstanding. The number of shares has decreased by -9.29% in one year.

Current Share Class	423.66M
Shares Outstanding	423.66M
Shares Change (YoY)	-9.29%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.46%
Owned by Institutions (%)	2.69%
Float	371.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.33
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-60.43
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.50

Financial Position

The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.03.

Current Ratio	5.46
Quick Ratio	3.73
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.43
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -0.61% and return on invested capital (ROIC) is -1.37%.

Return on Equity (ROE)	-0.61%
Return on Assets (ROA)	-1.17%
Return on Invested Capital (ROIC)	-1.37%
Return on Capital Employed (ROCE)	-2.04%
Revenue Per Employee	n/a
Profits Per Employee	-481,669
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BOM:534741 has paid 93,380 in taxes.

Income Tax	93,380
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.93% in the last 52 weeks. The beta is -0.14, so BOM:534741's price volatility has been lower than the market average.

Beta (5Y)	-0.14
52-Week Price Change	-37.93%
50-Day Moving Average	0.52
200-Day Moving Average	0.62
Relative Strength Index (RSI)	50.90
Average Volume (20 Days)	428,175

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-4.44M
Operating Income	-14.33M
Pretax Income	-3.76M
Net Income	-3.85M
EBITDA	-13.81M
EBIT	-14.33M
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 1.39 million in cash and 22.27 million in debt, giving a net cash position of -20.87 million or -0.05 per share.

Cash & Cash Equivalents	1.39M
Total Debt	22.27M
Net Cash	-20.87M
Net Cash Per Share	-0.05
Equity (Book Value)	647.20M
Book Value Per Share	1.53
Working Capital	182.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -51.58 million and capital expenditures -127,260, giving a free cash flow of -51.70 million.

Operating Cash Flow	-51.58M
Capital Expenditures	-127,260
Free Cash Flow	-51.70M
FCF Per Share	-0.12

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BOM:534741 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	9.29%
Shareholder Yield	n/a
Earnings Yield	-1.82%
FCF Yield	-24.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 14, 2013. It was a forward split with a ratio of 10.

Last Split Date	Aug 14, 2013
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	2